Results 41 to 50 of about 2,677 (178)

Long-term follow-up and treatment in nine boys with X-linked creatine transporter defect [PDF]

open access: yes, 2011
The creatine transporter (CRTR) defect is a recently discovered cause of X-linked intellectual disability for which treatment options have been explored.
Jiddeke M. van de Kamp   +11 more
core   +4 more sources

Diagnosis and Treatment of X-Linked Creatine Transporter Deficiency: Case Report and Literature Review

open access: yesBrain Sciences, 2023
(1) Background: X-linked creatine transporter deficiency (CTD) (OMIM 300036) is a rare group of inherited metabolic disorders characterized by global developmental delay/intellectual disability (GDD/ID), seizures, autistic behavior, and movement ...
Jiaqing Li, Sanqing Xu
doaj   +1 more source

Mild guanidinoacetate increase under partial guanidinoacetate methyltransferase deficiency strongly affects brain cell development. [PDF]

open access: yes, 2015
Among cerebral creatine deficiency syndromes, guanidinoacetate methyltransferase (GAMT) deficiency can present the most severe symptoms, and is characterized by neurocognitive dysfunction due to creatine deficiency and accumulation of guanidinoacetate in
Braissant, O.   +4 more
core   +1 more source

The genetic basis of non-syndromic intellectual disability: a review [PDF]

open access: yes, 2010
Intellectual disability (ID), also referred to as mental retardation (MR), is frequently the result of genetic mutation. Where ID is present together with additional clinical symptoms or physical anomalies, there is often sufficient information available
John B. Vincent   +2 more
core   +4 more sources

Screening for primary creatine deficiencies in French patients with unexplained neurological symptoms

open access: yesOrphanet Journal of Rare Diseases, 2012
A population of patients with unexplained neurological symptoms from six major French university hospitals was screened over a 28-month period for primary creatine disorder (PCD).
Cheillan David   +30 more
doaj   +1 more source

Tumour‐derived small extracellular vesicles suppress CD8+ T cell immune function by inhibiting SLC6A8‐mediated creatine import in NPM1‐mutated acute myeloid leukaemia

open access: yesJournal of Extracellular Vesicles, 2021
Acute myeloid leukaemia (AML) carrying nucleophosmin (NPM1) mutations has been defined as a distinct entity of acute leukaemia. Despite remarkable improvements in diagnosis and treatment, the long‐term outcomes for this entity remain unsatisfactory ...
Meixi Peng   +15 more
doaj   +1 more source

A Gad2 specific Slc6a8 deletion recapitulates the contextual and cued freezing deficits seen in Slc6a8<sup>-/y</sup> mice. [PDF]

open access: yesBrain Res
The creatine (Cr)-phosphocreatine shuttle is essential for ATP homeostasis. In humans, the absence of brain Cr causes significant intellectual disability, epilepsy, and language delay. Mutations of the creatine transporter (SLC6A8) are the most common cause of Cr deficiency.
Sugimoto C   +8 more
europepmc   +3 more sources

Molecular characteristics of circulating tumor cells resemble the liver metastasis more closely than the primary tumor in metastatic colorectal cancer [PDF]

open access: yes, 2016
Background: CTCs are a promising alternative for metastatic tissue biopsies for use in precision medicine approaches.
Biermann, K. (Katharina)   +18 more
core   +1 more source

Slc6a8-Mediated Creatine Uptake and Accumulation Reprogram Macrophage Polarization via Regulating Cytokine Responses [PDF]

open access: yesImmunity, 2019
Macrophage polarization is accompanied by drastic changes in L-arginine metabolism. Two L-arginine catalytic enzymes, iNOS and arginase 1, are well-characterized hallmark molecules of classically and alternatively activated macrophages, respectively.
Liangliang Ji   +8 more
openaire   +2 more sources

X-linked creatine transporter (SLC6A8) deficiency in females: Difficult to recognize, but a potentially treatable disease [PDF]

open access: yesMolecular Genetics and Metabolism, 2023
Creatine transporter deficiency (CTD), caused by pathogenic variants in SLC6A8, is the second most common cause of X-linked intellectual disability. Symptoms include intellectual disability, epilepsy, and behavioral disorders and are caused by reduced cerebral creatine levels.
Mejdahl Nielsen, Malene   +9 more
openaire   +4 more sources

Home - About - Disclaimer - Privacy